Perlecan is critical for heart stability

Cardiovascular Research

Volumn 80, Issue 3, 2008, Pages 435-444

  Sasse, Philipp ^a   Malan, Daniela ^a,b   Fleischmann, Michaela ^c   Roell, Wilhelm ^a   Gustafsson, Erika ^d   Bostani, Toktam ^a   Fan, Yun ^e   Kolbe, Thomas ^c   Breitbach, Martin ^a   Addicks, Klaus ^e   Welz, Armin ^a   Brem, Gottfried ^c   Hescheler, Jürgen ^e   Aszodi, Attila ^f   Costell, Mercedes ^g   Bloch, Wilhelm ^b   Fleischmann, Bernd K ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF COLOGNE   (Germany)

^f MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Basement membranes; Extracellular matrix; Hemopericard; Infarction; Ventricular function

Indexed keywords

COLLAGEN TYPE 4; LAMININ; PERLECAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; ELECTRON MICROSCOPY; EMBRYO; EMBRYONIC STEM CELL; HEART DEVELOPMENT; HEART FUNCTION; IMMUNOHISTOCHEMISTRY; LETHALITY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; BASEMENT MEMBRANE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FEMALE; HEART; HEPARAN SULFATE PROTEOGLYCANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; VENTRICULAR FUNCTION, LEFT;

EID: 56549087641     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn225     Document Type: Article

References (31)

1. Hassell JR, Robey PG, Barrach HJ, Wilczek J, Rennard SI, Martin GR. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci USA 1980;77:4494-4498.
2. Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R et al. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 1993;43:7-12.
3. Handler M, Yurchenco PD, Iozzo RV. Developmental expression of perlecan during murine embryogenesis. Dev Dyn 1997;210:130-145.
4. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 1999;147:1109-1122.
5. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet 1999;23:354-358.
6. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 2002;91:158- 164.
7. Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest 1998;102:1599-1608.
8. Fleischmann M, Bloch W, Kolossov E, Andressen C, Muller M, Brem G et al. Cardiac specific expression of the green fluorescent protein during early murine embryonic development. FEBS Lett 1998;440:370-376.
9. Wobus AM, Kleppisch T, Maltsev V, Hescheler J. Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels. In Vitro Cell Dev Biol Anim 1994;30A:425-434.
10. Ji GJ, Fleischmann BK, Bloch W, Feelisch M, Andressen C, Addicks K et al. Regulation of the L-type Ca2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J 1999;13:313-324.
11. Warren CM, Greaser ML. Method for cardiac myosin heavy chain separation by sodium dodecyl sulfate gel electrophoresis. Anal Biochem 2003;320:149-151.
12. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
13. Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW et al. Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 1997;139:265-278.
14. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J et al. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 1999;43:675-684.
15. Roell W, Fan Y, Xia Y, Stoecker E, Sasse P, Kolossov E et al. Cellular cardiomyoplasty in a transgenic mouse model. Transplantation 2002;73:462-465.
16. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007;450:819-824.
17. Georgakopoulos D, Kass DA. Estimation of parallel conductance by dual-frequency conductance catheter in mice. Am J Physiol Heart Circ Physiol 2000;279:H443-H450.
18. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327.
19. Rogalski TM, Williams BD, Mullen GP, Moerman DG. Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev 1993;7:1471-1484.
20. Ruiz P, Brinkmann V, Ledermann B, Behrend M, Grund C, Thalhammer C et al. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 1996;135:215-225.
21. Bierkamp C, McLaughlin KJ, Schwarz H, Huber O, Kemler R. Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 1996;180:780-785.
22. Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105:2435-2441.
23. van den Bos EJ, Mees BM, de Waard MC, de CR, Duncker DJ. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am J Physiol Heart Circ Physiol 2005;289:H1291-H1300.
24. Severs NJ. The cardiac muscle cell. Bioessays 2000;22:188- 199.
25. Tanaka N, Mao L, De Lano FA, Sentianin EM, Chien KR, Schmid-Schonbein GW et al. Left ventricular volumes and function in the embryonic mouse heart. Am J Physiol 1997;273:H1368-H1376.
26. Radice GL, Rayburn H, Matsunami H, Knudsen KA, Takeichi M, Hynes RO. Developmental defects in mouse embryos lacking N-cadherin. Dev Biol 1997;181:64-78.
27. Luo Y, Ferreira-Cornwell M, Baldwin H, Kostetskii I, Lenox J, Lieberman M et al. Rescuing the N-cadherin knockout by cardiac-specific expression. Development 2001;128:459-469.
28. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci 2004;117:73-84.
29. Bloch W, Fan Y, Han J, Xue S, Schoneberg T, Ji G et al. Disruption of cytoskeletal integrity impairs Gi-mediated signaling due to displacement of Gi proteins. J Cell Biol 2001;154:753-761.
30. Jensen JA, Kosek JC, Hunt TK, Goodson WH III, Miller DC. Cardiac cryolesions as an experimental model of myocardial wound healing. Ann Surg 1987;206:798-803.
31. Nakahama M, Murakami T, Kusachi S, Naito I, Takeda K, Ohnishi H et al. Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction. J Mol Med 2000;32:1087-1100.